Latest News - Moderna
Top Corporates Hub
Moderna
Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up
09.10.2026 15:48
Moderna's NASDAQ 100 debut triggered a surge in buying, but the real question is whether the rally holds once index funds finish their mechanical purchases and attention shifts back to the pipeline.
Reported Earlier: 'Cancer Vaccines Are the N.I.H's Next Big Bet' - The New York Times
09.10.2026 11:00
https://www.nytimes.com/2026/10/09/science/cancer-vaccines-nih-big-bet.html
Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday
09.10.2026 10:51
U.S. stocks rose Friday; Humana jumped 12.3% after improved 2027 Medicare Advantage ratings and reaffirmed FY26 EPS guidance.
Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development
09.10.2026 02:13
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced the appointments of Lakshmi Srinivasan, PhD, as Senior Vice President, Head of Translational Medicine, and Brandon Coder, PhD, as Vice President, Translational Sciences & Discovery. The appointments further strengthen the Company's global R&D capabilities in mRNA therapeutics, an
Moderna (MRNA) Was Removed From the Nasdaq-100 and Is Going Back In. What Changed?
09.10.2026 01:44
Moderna, Inc. (NASDAQ:MRNA) traded at around $196 on October 7, up 4.81% on the day and 571.42% higher over twelve months. Nasdaq said the company will rejoin the Nasdaq-100 before the open on October 9, replacing Warner Bros. Discovery. Moderna left that index in December 2024, and what has changed since is the market value […]
US Stock Market Today: S&P 500 Futures Hold Flat As Trade Deficit Worries Return
08.10.2026 08:11
The Morning Bull - US Market Morning Update Thursday, Oct, 8 2026 US Market stock futures are essentially flat, with E-mini S&P 500 contracts edging up only fractionally as investors weigh strong demand for imported goods against early signs of improving sentiment. The US trade deficit widened to a 17 month high of $105.6b in August, with imports hitting a record $420.8b. That points to solid consumer and business appetite, yet it can also add to price pressures through higher costs on...
US Stock Market Today: S&P 500 Futures Hold Flat As Trade Deficit Worries Return
08.10.2026 08:11
The Morning Bull - US Market Morning Update Thursday, Oct, 8 2026 US Market stock futures are essentially flat, with E-mini S&P 500 contracts edging up only fractionally as investors weigh strong demand for imported goods against early signs of improving sentiment. The US trade deficit widened to a 17 month high of $105.6b in August, with imports hitting a record $420.8b. That points to solid consumer and business appetite, yet it can also add to price pressures through higher costs on...
Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026?
08.10.2026 02:29
Axsome is posting 65% revenue growth but burning cash, while Moderna's vaccine market is cooling yet its oncology pipeline carries transformative potential.
Exploring the top movers within the S&P500 index during today's session.
07.10.2026 19:05
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday.
Cedar Grove Capital Q3 2026 Portfolio Update
07.10.2026 15:48
During the quarter, we closed our long positions in MTY Food Group, uniQure, ClearPoint Neuro, and Suja Life Inc. Read more here.
CPHI 2026: Moderna builds on its COVID-era manufacturing lessons
07.10.2026 14:43
The biotech’s VP of Drug Product Operations Michelle Rodriguez on how it works with CDMOs.
Tempus Announces Multi-Year Collaboration with Moderna and Merck
07.10.2026 12:30
CHICAGO, October 07, 2026--Tempus (NASDAQ: TEM) today announced an expanded, multi-year collaboration to support the potential commercialization of intismeran autogene (V940/mRNA-4157), a novel, potential first-in-class individualized neoantigen therapy (INT) being evaluated in combination with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with completely resected stage IIB-IV melanoma and other cancer types. Intismeran autogene is jointly developed by Moderna and Merck, know
Novavax and Moderna Shares Fall as Citi Assesses Vaccine Sector Volatility
07.10.2026 10:26
Shares of Novavax Inc (NASDAQ:NVAX) and Moderna Inc (NASDAQ:MRNA) declined on Wednesday after both companies rose in the previous session following reports of a suspected pneumonic plague case in Russia. Novavax shares fell 11% after gaining 20% on Tuesday, while Moderna declined 6% following a 7% increase in the prior session.
Moderna (MRNA) Could Be 57% Above Fair Value On New COO Appointment
07.10.2026 07:16
Moderna (MRNA) appointed former executive Juan Andres as its new Chief Operating Officer in a newly created role, giving investors additional information to weigh against a sharp recent move in the stock. Recent trading has been choppy for Moderna, with the share price down 7.8% over the past day and week, yet still posting a 28.8% 30 day share price return and a very large year to date gain, while the 1 year total shareholder return also remains very high despite a weaker 5 year record...
NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'
06.10.2026 03:34
No plague case has been confirmed, and no government orders have been announced, but outbreak-linked stocks jumped anyway.
NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'
06.10.2026 03:34
No plague case has been confirmed, and no government orders have been announced, but outbreak-linked stocks jumped anyway.
September's Leaders And Laggards
03.10.2026 00:30
Technology was the place to be among Septemberâs biggest S&P 500 winners, accounting for 13 of the monthâs 20 best-performing stocks.
ON Semi, Synaptics, Nike, Strategy, Moderna, and More Stocks That Explain Today’s Market
02.10.2026 11:35
Nike slumps after the retailer misses analysts’ first-quarter earnings target and issues downbeat fiscal-year guidance.
Warner Bros. Stock Is About to Leave the Nasdaq. Here’s What’s Replacing It.
02.10.2026 10:43
The entertainment company will exit the Nasdaq after it completes its merger with Paramount Skydance.